Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Kasten, Inc. (OTC: KAST).

Full DD Report for KAST

You must become a subscriber to view this report.


Recent News from (OTC: KAST)

U.S. District Court Rules Favorably for Kasten, Inc. on Basis of Legal Allegations Against Defendants Viaderma, Otiko and Phillips
SIOUX FALLS, S.D. , Feb. 26, 2018 /PRNewswire/ -- In mid-2017, Kasten, Inc. (PINK: KAST) joined OPD Holdings, LLC, as a Co-Plaintiff in a South Dakota federal district court lawsuit against several people and entities throughout the United States involving numerous business and i...
Source: PR Newswire
Date: February, 26 2018 13:41
Kasten, Inc. Releases Information To Address Recent OTC Markets Website Warning Label - "Caveat Emptor" - Posted In Response To Promotion Activity Concern
SIOUX FALLS, S.D. , Feb. 9, 2018 /PRNewswire/ -- Kasten, Inc. (PINK: KAST) today released an information update to address the recent Caveat Emptor warning label posted by OTC Markets Group, Inc. on the OTC Markets Group website in association with the Kasten stock symbol KAST (...
Source: PR Newswire
Date: February, 09 2018 13:06
DAKOTA Life Sciences Employing Blockchain Technology for New Global Pharmaceutical Security and Drug Resistance Monitoring
SIOUX FALLS, S.D. , Dec. 21, 2017 /PRNewswire/ -- Kasten Inc. (OTC:KAST) d/b/a DAKOTA Life Sciences has adopted blockchain technology for its new global drug protection software and information technology suite. Blockchain is a type of incorruptible digital ledger that was originally desi...
Source: PR Newswire
Date: December, 21 2017 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-100.00550.00550.00550.0055133
2018-12-07N/A0.0065N/AN/A0
2018-12-060.00650.00650.00650.00536,400
2018-12-05N/A0.0065N/AN/A0
2018-12-04N/A0.0065N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0636,40036,400100.0000Short
2018-11-0614,00019,10373.2869Short
2018-10-1630,000110,00027.2727Cover
2018-09-131,740131,1001.3272Cover
2018-09-105,0005,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on KAST.


About Kasten, Inc. (OTC: KAST)

Logo for Kasten, Inc. (OTC: KAST)

Kasten, Inc. dba DAKOTA Life Sciences is a biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising both in hospital and community settings. We are principally focused on delivering solutions to those people who are affected by antimicrobial resistance and who need superior pharmaceutical products at affordable prices.

 

Contact Information

 

 

Current Management

  • Steven J. Keough / President, COO
    • Mr. Steven J. Keough is the President and Chief Operating Officer of DAKOTA Life Sciences, an operating division of Kasten, and Chairman amp CEO of Arax Holdings Corp. OTCQB:ARAT . Mr. Keough has years of leadership and management experience in technology, and possesses senior business and legal experience as well. His prior public company experience included Senior Vice President of SurModics, Inc., a NASDAQ public company and provider of drug delivery and surface modification technologies to the life science industry. There was exceptional growth in the SurModics market valuation during his tenure. His achievements also include executive and operational management of both public and private companies and several decades working within the life sciences and drug delivery sectors. Mr. Keough received his Bachelor of Science Degree from the United States Naval Academy in Annapolis, Maryland, his Master of Arts in Congressional Studies from Catholic University of America, in Washington, D.C., and his Juris Doctor degree from the Boston College Law School, Newton Centre, Massachusetts. Additional executive training was obtained at the University of Chicago Graduate School of Business. Mr. Keough served in the U.S. military as a naval submarine officer and retired with the grade of Navy Captain.
  • James Cahill / CFO, CEO
  • Matheau J.W. Stout / Counsel

Current Share Structure

  • Market Cap: $2,062,540 - 03/19/2018
  • Authorized: 950,000,000 - 01/18/2018
  • Issue and Outstanding: 62,501,211 - 01/18/2018
  • Float: 20,501,211 - 01/18/2018

 


Recent Filings from (OTC: KAST)

Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current InformFiling Source: OTC Markets
Filing Date: February, 28 2018
Quarterly Report - Amended Financial Report for September 30, 2017
Filing Type: Quarterly Report - Amended Financial Report for September 30, 2017Filing Source: OTC Markets
Filing Date: February, 27 2018
Quarterly Report - Amended Financial Report for June 30, 2017
Filing Type: Quarterly Report - Amended Financial Report for June 30, 2017Filing Source: OTC Markets
Filing Date: February, 27 2018
Quarterly Report - Amended Financial Report for March 31, 2017
Filing Type: Quarterly Report - Amended Financial Report for March 31, 2017Filing Source: OTC Markets
Filing Date: February, 27 2018
Quarterly Report - Amended Financial Report for December 31, 2016
Filing Type: Quarterly Report - Amended Financial Report for December 31, 2016Filing Source: OTC Markets
Filing Date: February, 27 2018
Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current InformFiling Source: OTC Markets
Filing Date: February, 23 2018
Quarterly Report - Amended 2017 Q3 Consolidated Financial Statement
Filing Type: Quarterly Report - Amended 2017 Q3 Consolidated Financial StatementFiling Source: OTC Markets
Filing Date: February, 22 2018
Supplemental Information - KASTEN Press Release re Caveat Emptor Label
Filing Type: Supplemental Information - KASTEN Press Release re Caveat Emptor LabelFiling Source: OTC Markets
Filing Date: February, 09 2018
Supplemental Information - Attorney Letter
Filing Type: Supplemental Information - Attorney LetterFiling Source: OTC Markets
Filing Date: February, 09 2018
Supplemental Information - Supplemental Information to Q3 Disclosure Statement
Filing Type: Supplemental Information - Supplemental Information to Q3 Disclosure StatementFiling Source: OTC Markets
Filing Date: December, 20 2017

 

 


Daily Technical Chart for (OTC: KAST)

Daily Technical Chart for (OTC: KAST)


Stay tuned for daily updates and more on (OTC: KAST)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: KAST)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in KAST is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of KAST and does not buy, sell, or trade any shares of KAST. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/